Sign in
4

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0001133416-26-000002

Chief Medical Officer sold 8,125 shares at $4.07 ($33,089)

  • Chief Medical Officer acquired 8,125 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jamil Khurram · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-31 Exercise or conversion : show line 1 in the form 10b5-1 +8,125 $1.23 $9,994 8,125 D
2025-12-31 Sale : show line 2 in the form 10b5-1 −8,125 $4.07 $33,089 0 D
Open-market sales · 8,125 sh · avg $4.07 · $33,089

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-31 Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) −8,125 40,625 D
Loading xslF345X05/form4.xml…